1/ Policy makers: Wait, Isn’t quality of care better at large expensive health systems c/w independent practices?

Previous Research: Ummm no. But we can keep looking

@AHRQNews What if we look at high needs patients?

@RANDCorporation It’s ... worse?

onlinelibrary.wiley.com/doi/abs/10.111…
2/ To test hypothesis that health systems provide better care to patients w high needs, diff in quality b/w system‐affiliated & nonaffiliated physicians

ED visits were significantly *different* in system‐affiliated (117.5 per 100) & nonaffiliated POs (106.8 per 100, P < .0001).
3/ I love how delicately the RAND researchers approach this in their conclusion: “Health systems may not confer hypothesized quality advantages to patients with high needs.”

(Then why do they get paid so much more?)
4/ The usual response to these sort of findings from health systems is that they care for sicker patients.

So this paper only looked at sick patients, and then did every statistical manipulation known to humanity to look for and adjust for differences in the patients

Same diff

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Farzad Mostashari

Farzad Mostashari Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Farzad_MD

23 Sep
1/ How can we reduce Medicare spending without harming patients?

What we do @AledadeACO is transformative, but hard.

There are some low hanging fruit. This was one of them

Prior auth for repetitive, scheduled non-emergency ambulance transportation

cms.gov/newsroom/press…
2/ When CMS first released their public use files, I ran some analyses looking for aberrations-

One thing that jumped right out was...Repetitive non-emergency ambulance runs- often for the same person going back and forth to dialysis 3 times a week.

3/ In my blog @BrookingsInst back in 2014 I wrote:

"Medicare and law enforcement officials will need to create new processes for dealing with a potential flood of outlier reports from amateur sleuths like me."

But prevention >> fraud enforcement

brookings.edu/blog/up-front/…
Read 12 tweets
14 Sep
1/ Value-based care works. MSSP saved $2.6 billion dollars with $1.2 billion in net savings to Medicare, matching CBO’s savings expectations for 2019

Physician-led ACOs again out-performed hospital ACOs. What we need now is to help more practices participate in these models
2/ @AledadeACO is proud to be the largest, most successful nationwide enabler of physician-led ACOs, delivering better care at lower cost for >340,000 Medicare beneficiaries, saving Medicare and American taxpayers nearly $180 million in unnecessary health care spending last year!
3/ Here's the list of the physician-led ACOs we are supporting, and our performance data.

* It doesn't matter if you're urban, rural, suburban, or in which state

* It gets better. The longer you work, the more the chances of success

* More risk = Higher rewards
Read 10 tweets
8 Sep
1/ Some more peeks at age-specific COVID symptom trends from FB/CMU surveys at state level.

Here's Massachusetts and Maine

The rates are VERY LOW- the Northeast is the only oasis of green in the country on COVIDExitStrategy.org

but is there a worrisome trend developing? Image
2/ Look at the y axis for these states- GA/SC/TN/KY

Unlike MA/ME, they are persistently over 0.8% CLI rate , and heading thew wrong direction, including among the older age group.

Rising deaths will follow. Image
3/ The y axis jumps again-

MS and LA are very high, especially in youngest age group, but also 55+

They are also among the highest in test positivity.

We need to quench the outbreak in these states. If governments won't, then schools, businesses, families have to act Image
Read 5 tweets
7 Sep
1/ Why do I believe that COVID symptom survey data at SCALE could be a meaningful addition to the public health armamentarium?

Let me give you a glimpse- and I hope that you will be inspired to do your own analysis and join the symptomchallenge.org (and win the $50,000 prize)
2/ Background on the symptom survey- and how it might address some of the weaknesses of our existing public health surveillance methods is here:

3/ People who use facebook have been opting into these COVID-related surveys since April- at an unbelievable pace.

I ran a 10,000-person neighborhood random-digit survey in NYC for many years. I was very proud of it.

There are 8.8 MILLION survey responses in this dataset 🤯
Read 24 tweets
2 Sep
1/ We have heard about a number of potential breakthroughs for COVID response- large scale/cheap testing, immune therapy, vaccine progress.

But when it comes to "getting eyes on the outbreak" we are still peering through the same dirty windshields.

Could $100k change that?
2/ We *still* don't have a good answer to the most fundamental epidemiologic question - "what's the intensity of COVID activity in my community this week?"

We have lots of websites and lots of citizen scientists (including me) trying to piece it together

nytimes.com/2020/07/21/opi…
3/ This *matters*

We don't have a national strategy.
The CDC has been muzzled.
State/local leaders are mostly overwhelmed with trying to figure out what's going on, or have stopped looking at science altogether.

Businesses, schools, families have to decide for ourselves...
Read 20 tweets
21 Aug
1/ This is so bizarre

Closing the barn door 6 months after the horse left the barn, and 3 months after she moved to a different barn!

Trump administration bars FDA from regulating some laboratory tests, including for coronavirus

Let's review-

washingtonpost.com/health/2020/08…
2/ Like food, regulation of lab testing is complicated, but to simplify: if you want to package it up and sell it as a product you need FDA approval; if the tests are being done in-house, then it's "CLIA" - mostly CMS (w FDA and CDC).

But what about a public health emergency?
3/ In a public health emergency, you might want to allow people to try unproven treatments, or diagnostic tests, but with some oversight. That falls under "emergency use authorizations" of the FDA.

Lab-developed tests (remember normally under CMS/CLIA) would also be included
Read 10 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!